Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs.

MLA

Wang, Xiu Jun, et al. “Oxaliplatin Activates the Keap1/Nrf2 Antioxidant System Conferring Protection against the Cytotoxicity of Anticancer Drugs.” Free Radical Biology & Medicine, vol. 70, May 2014, pp. 68–77. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2014.02.010.

APA

Wang, X. J., Li, Y., Luo, L., Wang, H., Chi, Z., Xin, A., Li, X., Wu, J., & Tang, X. (2014). Oxaliplatin activates the Keap1/Nrf2 antioxidant system conferring protection against the cytotoxicity of anticancer drugs. Free Radical Biology & Medicine, 70, 68–77. https://doi.org/10.1016/j.freeradbiomed.2014.02.010

Chicago

Wang, Xiu Jun, Yinyan Li, Lin Luo, Hongyan Wang, Zhexu Chi, Ai Xin, Xin Li, Jiaguo Wu, and Xiuwen Tang. 2014. “Oxaliplatin Activates the Keap1/Nrf2 Antioxidant System Conferring Protection against the Cytotoxicity of Anticancer Drugs.” Free Radical Biology & Medicine 70 (May): 68–77. doi:10.1016/j.freeradbiomed.2014.02.010.